Duane Osterlind, LMFT
Duane Osterlind, LMFT
251: The Neuroscience of Addiction: A Game-Changing Approach with Dr. Paul Kenny
251: The Neuroscience of Addiction: A Game-Changing Approach with Dr. Paul Kenny
251: The Neuroscience of Addiction: A Game-Changing Approach with Dr. Paul Kenny
Monday 18th September 2023
Explore groundbreaking neuroscience research with Dr. Paul Kenny on addiction treatment strategies on the Addicted Mind Podcast.
44 minutes
informative
hopeful
scientific
innovative
About this podcast
Author:
Duane Osterlind, LMFT
Overview:
Categories:
Understanding Addiction & Recovery
Sobriety Toolkit
Recovery from Trauma
Family Recovery from Addiction
Navigating Intimate Relationships
Links:
Visit site
Episodes:
494 (View all)
Do you want to link to this podcast?
Get the buttons here!Neuroscience Breakthroughs in Addiction
Episode Overview
- Dr. Paul Kenny discusses GLP-1 modulators' potential in addiction treatment.
- Rodent brain studies reveal insights into addiction-like behaviors.
- Nicotinic acetylcholine receptors play a key role in addiction research.
- Cure Addiction Now supports innovative addiction research.
- Emerging treatments focus on controlling cravings and motivation.
It's crucial that if you're going to use something like these drugs, GLP-1 modulators or enhancers, you do carefully controlled human studies to make sure that the effects are real.
In this insightful episode of the Addicted Mind Podcast, host Duane Osterlind engages with Dr. Paul Kenny, a renowned figure in the field of neuroscience and addiction research. Dr. Kenny, who serves as the Ward Coleman Professor and Chair of the Nash Family Department of Neuroscience, as well as a research scientist with Cure Addiction Now, shares his groundbreaking work on the neuroscience of addiction and innovative treatment strategies. The discussion delves into Dr.
Kenny's research on the brains of rodents, aiming to uncover new signaling cascades that may influence addiction-like behaviors. His lab's focus is on understanding the neurobiological mechanisms underlying drug addiction, obesity, and schizophrenia, particularly the role of nicotinic acetylcholine receptors. Dr. Kenny's multidisciplinary approach combines complex behavioral paradigms, physiological analyses, and molecular biological techniques to advance this understanding.
A significant part of the conversation centers on the potential of GLP-1 modulators, such as semaglutides, to help control cravings and motivation in substance use disorders. These modulators, already known for their effectiveness in managing obesity, could also play a crucial role in addiction treatment by engaging satiety circuits that diminish the rewarding aspects of addictive drugs. Dr. Kenny emphasizes the need for carefully controlled human studies to validate these findings and explore the therapeutic possibilities. Dr.
Kenny's innovative work is supported by Cure Addiction Now, a nonprofit organization dedicated to funding research that seeks to overcome substance use disorders. His efforts illustrate the potential of leveraging broader biological systems to understand and treat addiction, offering hope for new therapeutic avenues. Listeners are encouraged to learn more about Dr. Kenny's work and Cure Addiction Now through various online resources.
The episode is a compelling exploration of the intersection between neuroscience and addiction, providing valuable insights into the future of addiction treatment.